Clinical Trials Logo

Type 2 Diabetes clinical trials

View clinical trials related to Type 2 Diabetes.

Filter by:

NCT ID: NCT00542113 Completed - Obesity Clinical Trials

Diabetes Virtual Trek: Obesity and Diabetes Prevention Through Science Enrichment

DvtENERGY
Start date: September 2001
Phase: N/A
Study type: Interventional

The purpose of this study was to evaluate the effectiveness of a school-to-home education program for it's ability to increase knowledge about, and ability to prevent type two diabetes in children and parents.

NCT ID: NCT00541983 Completed - Type 2 Diabetes Clinical Trials

Single-dose, Dose-escalation Study of Safety, PK, and Preliminary Efficacy of XOMA 052 in Type 2 Diabetes Mellitus

Start date: September 2007
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, pharmacokinetics (PK) and preliminary efficacy of XOMA 052 in subjects with active Type 2 Diabetes Mellitus (T2D). IV administration of XOMA 052 is likely to improve glycemic control in subjects with T2D by blocking certain receptors.

NCT ID: NCT00541879 Completed - Obesity Clinical Trials

Obesity and Diabetes Prevention Through Science Enrichment

DKENERGY
Start date: August 2001
Phase: N/A
Study type: Interventional

Type 2 diabetes and obesity in children continue to increase at alarming rates with devastating results. However, both these metabolic diseases are largely preventable through adoption of a healthy lifestyle, an understanding of what happens to food in the body, energy balance and some simple aspects of glucose regulation. Can elementary school children be taught the knowledge and skills necessary to prevent type 2 diabetes and obesity? Children need to learn this essential knowledge and practice these important health behavior skills. Elementary school may be an ideal place to master this subject that is a direct and logical extension of current health curricula including nutrition and physical activity blended with science and math.

NCT ID: NCT00541229 Completed - Type 2 Diabetes Clinical Trials

Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)

Start date: August 2007
Phase: Phase 1
Study type: Interventional

A study to assess the safety and efficacy of sitagliptin 100mg compared to sitagliptin 200mg in patients with type 2 diabetes.

NCT ID: NCT00536549 Completed - Type 2 Diabetes Clinical Trials

Effect of Real Time Continuous Glucose Monitoring System on the Management of Type 2 Diabetes

Start date: February 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether the Guardian Continuous Glucose Monitoring System in the home setting is more useful than frequent self blood glucose monitoring with a view to modifying patient's diet and exercise habits or improvement self disease control efforts and at last glycemic control in patients with type 2 diabetes

NCT ID: NCT00534014 Completed - Type 2 Diabetes Clinical Trials

Vitamin C and Cardiovascular Risk

Start date: January 2006
Phase: N/A
Study type: Interventional

Study Goal #1: Determine the optimal oral dose of vitamin C to reduce surrogate markers of atherosclerosis (blockages in blood vessels) following the consumption of an atherogenic high fat lunch in type 2 diabetic individuals. Study Goal #2: After conducting the original study, we found that vitamin E was not effective in reducing the markers of oxidative stress, hypercoagulation, inflammation, and metabolic parameters in patients with type 2 diabetes. To date, data from randomized trials have largely demonstrated no significant benefit of vitamin E supplementation on the prevention of primary and/or secondary cardiovascular disease as once thought. Therefore, we decided to amend our current protocol to add a Part B to study only the effects of vitamin C at the following doses: 500 mg, 1000 mg, and 2000 mg daily (and include a placebo arm, as well.

NCT ID: NCT00528879 Completed - Type 2 Diabetes Clinical Trials

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone

Start date: September 2007
Phase: Phase 3
Study type: Interventional

The purpose of this clinical research study is to learn whether dapagliflozin can help reduce blood sugar levels in participants with Type 2 diabetes that is not well controlled on metformin alone. The safety of this treatment will also be studied.

NCT ID: NCT00528372 Completed - Type 2 Diabetes Clinical Trials

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

Start date: September 2007
Phase: Phase 3
Study type: Interventional

The purpose of this clinical research study is to determine whether dapagliflozin can improve (decrease) blood glucose values in patients with Type 2 diabetes who have never been treated with medication or have been taking medication for less than 24 weeks since their original diabetes diagnosis. The safety of this treatment will also be studied.

NCT ID: NCT00527254 Completed - Type 2 Diabetes Clinical Trials

Telemedicine Influence in the Follow up of the Type 2 Diabetes Patient

Start date: October 2003
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the impact of a a real time teleassistance system in the clinical evolution of type 2 diabetic patients on self monitoring blood glucose in the Public National Primary Care System.

NCT ID: NCT00525629 Completed - Type 2 Diabetes Clinical Trials

The Metabolic Effects of Short-term Walnut Consumption in Subjects With the Metabolic Syndrome

Start date: February 2007
Phase: N/A
Study type: Interventional

Walnuts include many potentially beneficial micronutrients and phytochemicals, in this study we propose to examine the effects of walnuts independent of macronutrient content. The purpose of this proposal is to study in depth the short-term effects of walnut consumption in men and women with the metabolic syndrome. Study Aim 1: To investigate the effects of walnuts (48gms per day over 3 days) on insulin resistance in subjects with the metabolic syndrome. Study Aim 2: To investigate the effects of 48gms per day of walnuts over 3 days on lipids and inflammatory markers. Study Aim 3: To assess the possible mechanisms of the biological effects of short-term walnut consumption through assessment of adipokines, resting metabolic rate, gene expression in white blood cells and the effect of walnuts when consumed as part of a mixed meal, on glucose excursions, insulin secretion and the excretion of gut peptides and free fatty acids.